149 related articles for article (PubMed ID: 28525460)
21. Prediction of radionuclide bone imaging findings by Gleason histologic grading of prostate carcinoma.
Shih WJ; Mitchell B; Wierzbinski B; Magocum S; Ryo UY
Clin Nucl Med; 1991 Oct; 16(10):763-6. PubMed ID: 1742932
[TBL] [Abstract][Full Text] [Related]
22. Abnormal uptake in the sacrum on bone scan.
Ackerman L; Shirazi P; Van Drunen M
Semin Nucl Med; 2000 Jan; 30(1):67-9. PubMed ID: 10656246
[No Abstract] [Full Text] [Related]
23. [Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer].
Tanaka M; Murakami S; Akimoto S; Masai M; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1036-42. PubMed ID: 1507721
[TBL] [Abstract][Full Text] [Related]
24. Incidental detection of skeletal metastases on technetium-99m DTPA renal scintigraphy.
Prakash R
Australas Radiol; 1995 May; 39(2):182-4. PubMed ID: 7605328
[TBL] [Abstract][Full Text] [Related]
25. Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer.
Alexiou E; Georgoulias P; Valotassiou V; Georgiou E; Fezoulidis I; Vlychou M
Hell J Nucl Med; 2015; 18(1):77-8. PubMed ID: 25679079
[TBL] [Abstract][Full Text] [Related]
26. Metastatic superscan on (99m)Tc-methylene diphosphonate bone scintigraphy in pediatric neuroblastoma.
Arora S; Dhull VS; Mukherjee A; Tulsyan S; Behera A; Tripathi M
Indian J Nucl Med; 2015; 30(3):286-7. PubMed ID: 26170581
[TBL] [Abstract][Full Text] [Related]
27. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
28. Scoring systems of quantitative bone scanning in prostate cancer: historical overview, current status and future perspectives.
Zafeirakis A
Hell J Nucl Med; 2014; 17(2):136-44. PubMed ID: 24997079
[TBL] [Abstract][Full Text] [Related]
29. [Bone metastases of prostatic neoplasms with reference to the histological type and local tumor stage].
Langerhammer H; Steuer G; Gradinger R; Sintermann R; Pabst HW
Schweiz Med Wochenschr; 1980 Jan; 110(1):11-5. PubMed ID: 6244617
[TBL] [Abstract][Full Text] [Related]
30. The headless bone scan: an uncommon manifestation of metastatic superscan in carcinoma of the prostate.
Massie JD; Sebes JI
Skeletal Radiol; 1988; 17(2):111-3. PubMed ID: 3363378
[TBL] [Abstract][Full Text] [Related]
31. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
[TBL] [Abstract][Full Text] [Related]
32. Bone scintigraphy in the initial staging of patients with renal-cell carcinoma: concise communication.
Rosen PR; Murphy KG
J Nucl Med; 1984 Mar; 25(3):289-91. PubMed ID: 6699721
[TBL] [Abstract][Full Text] [Related]
33. Solitary Thumb Acrometastasis Identified on Bone Scintigraphy.
Xie P; Huang J
Clin Nucl Med; 2017 Jul; 42(7):549-550. PubMed ID: 28240671
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of bone scintigraphy as a staging investigation for oesophageal carcinoma.
Jennings NA; Griffin SM; Lamb PJ; Preston S; Richardson D; Karat D; Hayes N
Br J Surg; 2008 Jul; 95(7):840-4. PubMed ID: 18551472
[TBL] [Abstract][Full Text] [Related]
35. Visualization in the ipsilateral lymph nodes secondary to extravasation of a bone-imaging agent in the left hand: a case report.
Shih WJ; Collins J; Kiefer V
J Nucl Med Technol; 2001 Sep; 29(3):154-5. PubMed ID: 11564840
[TBL] [Abstract][Full Text] [Related]
36. Bony expansion in skeletal metastases from carcinoma of the prostate as seen by bone scintigraphy.
Resnik CS; Garver P; Resnick D
South Med J; 1984 Oct; 77(10):1331-5. PubMed ID: 6484659
[TBL] [Abstract][Full Text] [Related]
37. [Absent kidney sign in the bone scintigraphy].
Odano I; Sato Y; Kimura M; Sakai K
Rinsho Hoshasen; 1984 Nov; 29(12):1453-4. PubMed ID: 6521011
[No Abstract] [Full Text] [Related]
38. Tracheal uptake on Tc-99m MDP bone scintigraphy can be a potential source of false-positive results in a prostate cancer patient.
Sood A; Sethi S; Kumar R
Clin Nucl Med; 2010 Jun; 35(6):454-5. PubMed ID: 20479601
[No Abstract] [Full Text] [Related]
39. Unusual presentation of extraosseous metastases on bone scintigraphy.
Xie W; Padhy AK; Wong WY
Clin Nucl Med; 2012 Aug; 37(8):793-7. PubMed ID: 22785515
[TBL] [Abstract][Full Text] [Related]
40. The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Tabrizipour AI; Dunne M
Clin Nucl Med; 2015 May; 40(5):e285-6. PubMed ID: 25608148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
